Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Perspective Therapeutics, Inc. (CATX) had Weighted-Average Shares Outstanding (Diluted) of 64.42M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.45M |
|
$-79.28M |
|
-- |
|
$1.45M |
|
$92.34M |
|
$-90.89M |
|
$10.46M |
|
$-80.43M |
|
$-80.43M |
|
$-80.43M |
|
$-80.43M |
|
$-79.28M |
|
$-80.43M |
|
$-90.89M |
|
$-65.12M |
|
64.42M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
64.42M |
$-1.23 |
|
$-1.23 |
|
| Balance Sheet Financials | |
$231.16M |
|
$57.32M |
|
$109.94M |
|
$341.10M |
|
$18.23M |
|
$1.62M |
|
$32.20M |
|
$50.43M |
|
$290.67M |
|
$240.67M |
|
$290.67M |
|
70.67M |
|
| Cash Flow Statement Financials | |
$-18.29M |
|
$-218.93M |
|
$289.38M |
|
$9.42M |
|
$61.58M |
|
$52.16M |
|
$5.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.68 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-6250.76% |
|
-6250.76% |
|
-4479.02% |
|
-5531.43% |
|
-5452.48% |
|
$-72.37M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
12.53 |
|
29.12 |
|
-27.67% |
|
-33.42% |
|
-23.58% |
|
-27.52% |
|
$4.11 |
|
$-1.12 |
|
$-0.28 |
|